A.T. Cross Company (Nasdaq:ATX), announced that David G. Whalen, Chief Executive Officer and President, will present at the LD Micro Investor Conference on Thursday, December 8, 2011. The conference will have 101 companies presenting over two days and is being held at the Luxe Sunset Bel Air Hotel in Los Angeles, California. Management's presentation is scheduled to begin at 9:00 AM PST (12:00 PM EST). The presentation will be webcast live and may be accessed at the Company's website, www.cross.com.

A.T. Cross Company designs and markets branded personal and business accessories worldwide.

Read full article at: http://crweselect.com/27641/stock-alerts/atx-clno-ixys-cvv-notable-stock-by-crweselectcom/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

*******************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit,Inc. (CLNO.OB).

Ventrus Biosciences, Inc. (NASDAQ:VTUS)

VTUS previously announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Iferanserin ointment (VEN 309) is for the topical treatment of symptomatic hemorrhoids. Hemorrhoids, which are characterized by the inflammation and swelling of veins around the anus or lower rectum, can cause bleeding, itching, pain and difficulty defecating. Based on a report by the National Institute of Diabetes and Digestive Kidney Diseases, the Company estimate that symptomatic hemorrhoids currently affect approximately 12.5 million adults in the U.S. Despite such a high prevalence, the Company is not aware of any FDA-approved prescription drugs for the treatment of hemorrhoids in the U.S. Iferanserin has highly selective, antagonistic activity against peripheral 5-HT2A receptors involved in clotting and the contraction of arteries and veins, two events believed to be associated with hemorrhoid formation. By limiting 5-HT2A receptor activity, VEN 309 improves the flow of blood out of the dilated veins that comprise the hemorrhoid, thereby reducing bleeding, itchiness and pain.

Read full article at: http://crweselect.com/27426/stock-alerts/vtus-crwe-dci-ceg-aet-crweselectcom-stock-news-ventrus-biosciences-crown-equity-holdings-donaldson-company-constellation-energy-group-aetna-inc-video-included-inside/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

VTUScrweselect1120
CRWEcrweselect1120

crweselectlogo-1

chartstockalert


Deer Consumer Products, Inc. (NasdaqEER) announced that Deer is scheduled to pay on October 14, 2011, its regular quarterly cash dividend of $0.05 per share to shareholders of record as of September 30, 2011.

Deer Consumer Products, Inc., through its subsidiaries, engages in the design, manufacture, and sale of small home and kitchen electronic appliances.

**************************************

enzo-logoEnzo Biochem Inc. (ENZ)

Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.

( Read the full article and the disclaimer at http://crweselect.com/26344/stock-alerts/gblhfpk-hcii-nbix-mjgcfpk-vtss-stocks-in-action-by-crweselectcom/)

Netlist Inc. (Nasdaq:NLST) announced that its 8GB and 16GB HyperCloud™ Memory module has been qualified on GIGABYTE's high density server motherboard. GIGABYTE (TPE: 2376) is the leading manufacturer of motherboards, graphics cards and other computing hardware solutions. The integration of HyperCloud memory on GIGABYTE's GA-7TESM server motherboard enables 288GB of memory capacity running at 1333 MT/s.

Netlist, Inc., together with its subsidiaries, engages in the design, manufacture, and sale of intelligent memory subsystems for the datacenter server, high-performance computing, and communications markets primarily in the United States and the People's Republic of China.

*********************************

Superconductor Technologies Inc. (Nasdaq:SCON) is scheduled to present at the 2011 EUCAS-ISEC-ICMC Superconductivity Centennial Conference being held at the World Forum Conference Centre in The Hague, The Netherlands. Brian Moeckly, STI's Director of Materials Research & Development, will present on Tuesday, September 20th at 12:45 CET.

Superconductor Technologies, Inc. engages in the research, development, manufacture, and marketing of infrastructure products for wireless voice and data applications. It provides interference elimination and network enhancement solutions to the commercial wireless industry.

(Read more on http://crweselect.com/26298/stock-alerts/nlst-scon-crwe-cybi-stocks-in-review-by-crweselectcom/)